Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-May-18 12:38 PM View:  | Nolan Sean P. President & CEO Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 11,000 | -- | -- | (100%) 11.0K to 0 | |
| 15-May-18 12:35 PM View: | Manning Paul B Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 228,752 | -- | -- | (16%) 1.46M to 1.23M | |
| 15-May-18 12:36 PM View: | Modi Rick Chief Business Officer | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 2,500 | -- | -- | (100%) 2.5K to 0 | |
| 15-May-18 12:40 PM View: | Siffert Joao Md Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,106 | -- | -- | (100%) 1.11K to 0 | |
| 15-May-18 12:33 PM View: | Koh Bong Y Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,035,660 | -- | -- | (100%) 1.04M to 0 | |
| 15-May-18 12:42 PM View: | Verwiel Frank Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,106 | -- | -- | (100%) 1.11K to 0 | |
| 15-May-18 12:34 PM View: | Litalien James J SrVP/Chief Reg&Quality Officer | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 3,800 | -- | -- | (100%) 3.8K to 0 | |
| 15-May-18 12:35 PM View: | Manning Paul B Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,226,450 | -- | -- | (100%) 1.23M to 0 | |
| 15-May-18 12:30 PM View: | Johannesen Michael General Counsel | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 2,500 | -- | -- | (100%) 2.5K to 0 | |
| 15-May-18 12:37 PM View: | Nagendran Sukumar Sr. VP & Chief Medical Officer | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 3,800 | -- | -- | (100%) 3.8K to 0 | |
| 15-May-18 12:33 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 8,800 | -- | -- | (100%) 8.8K to 0 | |
| 15-May-18 12:41 PM View: | Smith Lori J. SVP-Chief Human Resource Off. | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 2,308 | -- | -- | (100%) 2.31K to 0 | |
| 15-May-18 12:39 PM View: | Session R.A. II Sr. VP, Corp Strategy | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,667 | -- | -- | (100%) 1.67K to 0 | |
| 15-May-18 12:29 PM View: | Donenberg Philip B Chief Financial Officer | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 3,800 | -- | -- | 100% 0 to 3.8K | |
| 15-May-18 12:31 PM View: | Kaspar Brian K. Chief Scientific Officer Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,764,140 | -- | -- | (100%) 1.76M to 0 | |
| 15-May-18 12:32 PM View: | Kearney Terrence C Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,106 | -- | -- | (100%) 1.11K to 0 | |
| 15-May-18 12:33 PM View: | Koh Bong Y Director | Avexis, Inc. (AVXS) | 15-May-18 | Disposition | 1,106 | -- | -- | (< 1%) 1.04M to 1.04M | |
| 04-Apr-18 4:56 PM View: | Litalien James J SrVP/Chief Reg&Quality Officer | Avexis, Inc. (AVXS) | 02-Apr-18 | Option Exercise | 5,000 | $18.17 | $90,850.00 | 132% 3.8K to 8.8K | |
| 04-Apr-18 4:57 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 02-Apr-18 | Option Exercise | 2,000 | $18.17 | $36,340.00 | 23% 8.8K to 10.8K | |
| 04-Apr-18 4:57 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 02-Apr-18 | Market Option Sale (Planned) | 2,000 | $119.49 | $238,982.00 | (19%) 10.8K to 8.8K | (82%) |
| 04-Apr-18 4:58 PM View: | Kaspar Brian K. Chief Scientific Officer Director | Avexis, Inc. (AVXS) | 02-Apr-18 | Market Sale (Planned) | 15,000 | $119.50 | $1,792,440.00 | (< 1%) 1.77M to 1.76M | (82%) |
| 04-Apr-18 4:56 PM View: | Litalien James J SrVP/Chief Reg&Quality Officer | Avexis, Inc. (AVXS) | 02-Apr-18 | Market Option Sale (Planned) | 5,000 | $119.44 | $597,213.00 | (57%) 8.8K to 3.8K | (82%) |
| 27-Mar-18 5:31 PM View: | Litalien James J SrVP/Chief Reg&Quality Officer | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 3,800 | -- | -- | 100% 0 to 3.8K | |
| 27-Mar-18 5:28 PM View: | Johannesen Michael General Counsel | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 27-Mar-18 5:33 PM View: | Nagendran Sukumar Sr. VP & Chief Medical Officer | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 3,800 | -- | -- | 100% 0 to 3.8K | |
| 27-Mar-18 5:30 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 3,800 | -- | -- | 76% 5.0K to 8.8K | |
| 27-Mar-18 5:34 PM View: | Smith Lori J. SVP-Chief Human Resource Off. | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 2,308 | -- | -- | 100% 0 to 2.31K | |
| 30-Mar-18 6:07 PM View: | Koh Bong Y Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | < 1% 1.04M to 1.04M | |
| 27-Mar-18 5:34 PM View: | Session R.A. II Sr. VP, Corp Strategy | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,667 | -- | -- | 100% 0 to 1.67K | |
| 27-Mar-18 5:27 PM View: | Donenberg Philip B Chief Financial Officer | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 3,800 | -- | -- | 100% 0 to 3.8K | |
| 27-Mar-18 5:29 PM View: | Kaspar Brian K. Chief Scientific Officer Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 3,800 | -- | -- | < 1% 1.77M to 1.77M | |
| 30-Mar-18 5:54 PM View: | Kearney Terrence C Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | 100% 0 to 1.11K | |
| 30-Mar-18 5:50 PM View: | Welch Daniel G Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | 100% 0 to 1.11K | |
| 27-Mar-18 5:26 PM View: | Nolan Sean P. President & CEO Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 11,000 | -- | -- | 100% 0 to 11.0K | |
| 27-Mar-18 5:32 PM View: | Modi Rick Chief Business Officer | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 30-Mar-18 5:55 PM View: | Siffert Joao Md Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | 100% 0 to 1.11K | |
| 30-Mar-18 5:51 PM View: | Verwiel Frank Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | 100% 0 to 1.11K | |
| 30-Mar-18 5:51 PM View: | Manning Paul B Director | Avexis, Inc. (AVXS) | 13-Mar-18 | Grant | 1,106 | -- | -- | < 1% 1.45M to 1.46M | |
| 09-Mar-18 5:04 PM View: | Nolan Sean P. President & CEO Director | Avexis, Inc. (AVXS) | 07-Mar-18 | Option Exercise | 10,000 | $15.94 | $159,400.00 | 100% 0 to 10.0K | |
| 09-Mar-18 5:04 PM View: | Nolan Sean P. President & CEO Director | Avexis, Inc. (AVXS) | 07-Mar-18 | Market Option Sale (Planned) | 10,000 | $129.47 | $1,294,660.00 | (100%) 10.0K to 0 | (68%) |
| 05-Mar-18 4:36 PM View: | Nagendran Sukumar Sr. VP & Chief Medical Officer | Avexis, Inc. (AVXS) | 01-Mar-18 | Option Exercise | 1,780 | $18.47 | $32,876.60 | 100% 0 to 1.78K | |
| 05-Mar-18 4:36 PM View: | Nagendran Sukumar Sr. VP & Chief Medical Officer | Avexis, Inc. (AVXS) | 01-Mar-18 | Market Option Sale (Planned) | 1,780 | $126.19 | $224,618.00 | (100%) 1.78K to 0 | (73%) |
| 05-Mar-18 4:38 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 01-Mar-18 | Option Exercise | 2,000 | $18.17 | $36,340.00 | 40% 5.0K to 7.0K | |
| 05-Mar-18 4:38 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 01-Mar-18 | Market Option Sale (Planned) | 2,000 | $126.12 | $252,243.00 | (29%) 7.0K to 5.0K | (73%) |
| 05-Mar-18 4:37 PM View: | Kaspar Brian K. Chief Scientific Officer Director | Avexis, Inc. (AVXS) | 01-Mar-18 | Market Sale (Planned) | 15,000 | $126.15 | $1,892,190.00 | (< 1%) 1.78M to 1.77M | (73%) |
| 05-Feb-18 4:58 PM View: | Nagendran Sukumar Sr. VP & Chief Medical Officer | Avexis, Inc. (AVXS) | 01-Feb-18 | Option Exercise | 1,780 | $18.47 | $32,876.60 | 100% 0 to 1.78K | |
| 05-Feb-18 4:58 PM View: | Nagendran Sukumar Sr. VP & Chief Medical Officer | Avexis, Inc. (AVXS) | 01-Feb-18 | Market Option Sale (Planned) | 1,780 | $117.96 | $209,969.00 | (100%) 1.78K to 0 | (85%) |
| 05-Feb-18 4:56 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 01-Feb-18 | Option Exercise | 2,000 | $18.17 | $36,340.00 | 40% 5.0K to 7.0K | |
| 05-Feb-18 4:56 PM View: | Knudten Andrew F. SrVP/Manufacture&Supply Chain | Avexis, Inc. (AVXS) | 01-Feb-18 | Market Option Sale (Planned) | 2,000 | $118.13 | $236,253.00 | (29%) 7.0K to 5.0K | (84%) |
| 05-Feb-18 4:57 PM View: | Kaspar Brian K. Chief Scientific Officer Director | Avexis, Inc. (AVXS) | 01-Feb-18 | Market Sale (Planned) | 15,000 | $118.07 | $1,771,010.00 | (< 1%) 1.8M to 1.78M | (84%) |
